Differences in clinical features between axial psoriatic arthritis and axial spondyloarthritis: a systematic review and meta-analysis of observational studies - Top-Institutions - MDSpire

Differences in clinical features between axial psoriatic arthritis and axial spondyloarthritis: a systematic review and meta-analysis of observational studies

  • By

  • Zhihao Qiu

  • Zijie Chen

  • Zhe Yang

  • Ruibo Xia

  • Weikai Chen

  • Yuwei Zhu

  • Weijie Wang

  • Zhengfu Li

  • Kepeng Yang

  • June 22, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
    Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

    Unknown, Unknown

    Key Differentiators

    • Rheumatology

  • #2

    Assessment of SpondyloArthritis International Society
    Assessment of SpondyloArthritis International Society

    Unknown, Unknown

    Key Differentiators

    • Rheumatology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Rheumatology

  • #4

    DANBIO registry
    DANBIO registry

    Unknown, Unknown

    Key Differentiators

    • Rheumatology

  • #5

    DESIR cohort
    DESIR cohort

    Unknown, Unknown

    Key Differentiators

    • Rheumatology

Original Source(s)

Differences in clinical features between axial psoriatic arthritis and axial spondyloarthritis: a systematic review and meta-analysis of observational studies

  • by Zhihao Qiu, Zijie Chen, Zhe Yang, Ruibo Xia, Weikai Chen, Yuwei Zhu, Weijie Wang, Zhengfu Li, Kepeng Yang

  • June 22, 2026

Related Content

Bimekizumab in Psoriasis: 3-Year Outcomes

Investigators compare patient-reported symptoms and quality-of-life outcomes vs secukinumab.

FDA Expands Guselkumab Label in PsA

Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.